Demant A/S Stock Forecast, Price & News

+0.34 (+1.19 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume673 shs
Average Volume1,249 shs
Market Capitalization$13.92 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive WILYY News and Ratings via Email

Sign-up to receive the latest news and ratings for Demant A/S and its competitors with MarketBeat's FREE daily newsletter.

Demant A/S logo

About Demant A/S

Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates through two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment offers headsets and solutions for the professional call center, office, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.


Demant A/S (OTCMKTS:WILYY) Short Interest Update
Demant A/S (OTCMKTS:WILYY) Short Interest Update
June 14, 2021 |  americanbankingnews.com
Demant A/S (OTCMKTS:WILYY) Reaches New 52-Week High at $29.61
Demant A/S (OTCMKTS:WILYY) Reaches New 52-Week High at $29.61
June 8, 2021 |  americanbankingnews.com
Demant A/S (OTCMKTS:WILYY) Hits New 52-Week High at $27.63
Demant A/S (OTCMKTS:WILYY) Hits New 52-Week High at $27.63
June 2, 2021 |  americanbankingnews.com
Short Interest in Demant A/S (OTCMKTS:WILYY) Drops By 44.4%
Short Interest in Demant A/S (OTCMKTS:WILYY) Drops By 44.4%
May 29, 2021 |  americanbankingnews.com
Demant A/S (WILYY)
Demant A/S (WILYY)
March 18, 2021 |  au.finance.yahoo.com
Demant A/S to Host Earnings Call
Demant A/S to Host Earnings Call
February 9, 2021 |  finance.yahoo.com
Demant A/S ADR
Demant A/S ADR
November 2, 2020 |  wsj.com
Demant A/S: Interim Management Statement
Demant A/S: Interim Management Statement
October 13, 2020 |  uk.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.76 out of 5 stars

Medical Sector

1271st out of 2,100 stocks

Surgical Appliances & Supplies Industry

30th out of 40 stocks

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Demant A/S (OTCMKTS:WILYY) Frequently Asked Questions

Is Demant A/S a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Demant A/S in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Demant A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WILYY, but not buy additional shares or sell existing shares.
View analyst ratings for Demant A/S
or view top-rated stocks.

What stocks does MarketBeat like better than Demant A/S?

Wall Street analysts have given Demant A/S a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Demant A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Demant A/S?

Demant A/S saw a decline in short interest in the month of May. As of May 28th, there was short interest totaling 300 shares, a decline of 40.0% from the May 13th total of 500 shares. Based on an average daily trading volume, of 1,300 shares, the short-interest ratio is currently 0.2 days.
View Demant A/S's Short Interest

How has Demant A/S's stock price been impacted by COVID-19?

Demant A/S's stock was trading at $16.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WILYY shares have increased by 80.1% and is now trading at $28.99.
View which stocks have been most impacted by COVID-19

Who are Demant A/S's key executives?

Demant A/S's management team includes the following people:
  • Mr. Søren Nielsen, CEO, Pres & Member of Exec. Board (Age 51, Pay $2.05M)
  • Mr. René Schneider, CFO & Member of Exec. Board (Age 48, Pay $900.14k)
  • Mathias Holten Møller, Director of Investor Relations
  • Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & Relations
  • Mr. Finn Mohring, Sr. VP of R&D
  • Mr. Jes Olsen, Pres of Oticon Medical
  • Mr. Christian Lange, Investor Relations Officer

Who are some of Demant A/S's key competitors?

What is Demant A/S's stock symbol?

Demant A/S trades on the OTCMKTS under the ticker symbol "WILYY."

How do I buy shares of Demant A/S?

Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Demant A/S's stock price today?

One share of WILYY stock can currently be purchased for approximately $28.99.

How much money does Demant A/S make?

Demant A/S has a market capitalization of $13.92 billion and generates $2.24 billion in revenue each year.

How many employees does Demant A/S have?

Demant A/S employs 15,837 workers across the globe.

What is Demant A/S's official website?

The official website for Demant A/S is www.demant.com.

Where are Demant A/S's headquarters?

Demant A/S is headquartered at Kongebakken 9, Smorum G7, 2765.

How can I contact Demant A/S?

Demant A/S's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at 45-3917-7300 or via email at [email protected]

This page was last updated on 6/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.